Anal Cancer Ajcc V8

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-04-22
Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer [Phase 2]
This phase 2 trial update assesses nivolumab with or without ipilimumab in patients with refractory metastatic anal canal cancer, with resul…